Kurapa kwezvirwere zveganda, urinary tract infections, zvirwere zvekufema, gastrointestinal tract infections uye zvirwere zvemuromo wemukanwa mumbwa.

COMPOSITION

Tafura yega yega ine:
Amoxicillin (seamoxicillin trihydrate) 250 mg
Clavulanic acid (se potassium clavulanate) 62.5 mg

 Zviratidzo zvekushandisa, zvichitsanangura mhando dzakanangwa

Kurapa kwezvirwere mumbwa zvinokonzerwa nemabhakitiriya anonzwisisaamoxicillin yakabatana ne clavulanic acid, kunyanya: Zvirwere zveganda (kusanganisira zvepamusoro uye zvakadzika pyodermas) zvine chekuita neStaphylococci (inosanganisira beta-lactamase inoburitsa strains) uye Streptococci.
Urinary tract infections inobatanidza neStaphylococci (kusanganisira beta-lactamase inogadzira strains), Streptococci, Escherichia coli (kusanganisira beta-lactamase inogadzira strains), Fusobacterium necrophorum uye Proteus spp.
Zvirwere zvekufema zvine chekuita neStaphylococci (kusanganisira beta-lactamase inogadzira strains), Streptococci uye Pasteurellae.
Zvirwere zvemudumbu zvine chekuita neEscherichia coli (kusanganisira beta-lactamase inogadzira strains) uye Proteus spp.
Utachiona hwemukanwa mhango (mucous membrane) yakabatana neClostridia, Corynebacteria, Staphylococci (kusanganisira beta-lactamase inogadzira strains), Streptococci, Bacteroides spp (kusanganisira beta-lactamase inoburitsa strains), Fusobacterium necrophorum uye Pasteurellae.

Dosage
Chiyero chinokurudzirwa ndeye 12.5 mg yezvakasanganiswa zvinoshanda zvinhu (= 10 mgamoxicillinuye 2.5 mg clavulanic acid) pakg bodyweight, kaviri pazuva.
Tafura inotevera inoitirwa segwara rekugovera chigadzirwa pachiyero chedosi ye12.5 mg yeakasanganiswa anoshanda pakg bodyweight kaviri pazuva.
Muzviitiko zvinoramba zvehutachiona hweganda, dosi yakapetwa kaviri inokurudzirwa (25 mg pakg bodyweight, kaviri pazuva).

Pharmacodynamic properties

Amoxicillin/clavulanate ine huwandu hwakasiyana hwekuita hunosanganisira βlactamase inogadzira madhiri ezvese Gram-positive uye Gram-negative aerobes, facultative anaerobes uye obligate anaerobes.

Kubatwa zvakanaka kunoratidzwa nemabhakitiriya akati wandei anosanganisira Staphylococci (kusanganisira beta-lactamase inogadzira strains, MIC90 0.5 μg/ml), Clostridia (MIC90 0.5 μg/ml), Corynebacteria uye Streptococci, uye gram-negative mabhakitiriya anosanganisira Bactero-negative betalactamase inogadzira strains, MIC90 0.5 μg/ml), Pasteurellae (MIC90 0.25 μg/ml), Escherichia coli (inosanganisira beta-lactamase inogadzira strains, MIC90 8 μg/ml) uye Proteus μ0 μg/mIC (MIC).Variable susceptibility inowanikwa mune imwe E. coli.

Sherufu hupenyu
Sherufu-hupenyu hwechigadzirwa chemishonga yezvipfuyo seyakarongedzerwa kutengeswa: makore maviri.
Sherufu-hupenyu hwemahwendefa emakamuri: maawa gumi nemaviri.

Kuchenjerera kwakakosha kwekuchengetedza
Usachengete kupfuura 25°C.
Chengetedza mumudziyo wekutanga.
Quarter tablets inofanira kudzorerwa kumutsara wakazaruka uye kuchengetwa mufiriji.